N@N

NPO, BUSE, RNST, XNPT, DRC, ZIOP Are Seasonally Ripe To Go Up In the Next Five Weeks

March 11, 2013 / M2 PRESSWIRE / BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of EnPro Industries Inc (NYSE:NPO), First Busey Corp (NASDAQ:BUSE), Renasant Corp (NASDAQ:RNST), Xenoport Inc (NASDAQ:XNPT), Dresser-Rand Group Inc (NYSE:DRC), ZIOPHARM Oncology Inc (NASDAQ:ZIOP) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at: http://www.squeezetrigger.com/services/strat/mh.php

The following stocks are expected to go Up:

  Symbol  Company                          Expected Return  Odds                 By The Following Date
  NPO     EnPro Industries Inc             12.27%           90.00% (9 of 10)     Thursday, April 18th 2013
  BUSE    First Busey Corp                 7.94%            84.62% (11 of 13)    Tuesday, April 2nd 2013
  RNST    Renasant Corp                    7.75%            84.62% (11 of 13)    Tuesday, April 2nd 2013
  XNPT    Xenoport Inc                     15.65%           85.71% (6 of 7)      Wednesday, April 17th 2013
  DRC     Dresser-Rand Group Inc           13.80%           85.71% (6 of 7)      Tuesday, April 23rd 2013
  ZIOP    ZIOPHARM Oncology Inc            13.51%           85.71% (6 of 7)      Tuesday, March 26th 2013

EnPro Industries Inc (NYSE:NPO) - EnPro Industries, Inc. engages in the design, development, manufacture, and marketing of engineered industrial products primarily in the United States and Europe. The company operates in three segments: Sealing Products, Engineered Products, and Engine Products. The Sealing Products segment provides metallic, non-metallic, and composite material gaskets; dynamic seals; compression packing; resilient metal and elastomeric seals; hydraulic components; expansion joints; heavy-duty truck wheel-end component systems, including brake products; flange sealing and isolation products; pipeline casing spacers/isolators; casing end seals; sealing systems for sealing pipeline penetrations; hole forming products; manhole infiltration sealing systems; signage for pipelines; bellows and bellows assemblies; pedestals for semiconductor manufacturing; PTFE products; conveyor belting; and sheeted rubber products. Its products are used in various industries, including chemical and petrochemical processing, petroleum extraction and refining, pulp and paper processing, heavy-duty trucking, power generation, food and pharmaceutical processing, primary metal manufacturing, mining, water and waste treatment, aerospace, medical, filtration, and semiconductor fabrication. The Engineered Products segment offers bearing products and aluminum bushing blocks for use in automotive, pump and compressor, construction, power generation, and general industrial markets; and components for reciprocating compressors and engines for use in refining, petrochemical, natural gas gathering, storage and transmission, and general industrial markets. The Engine Products segment provides heavy-duty, medium-speed diesel, natural gas, and dual fuel reciprocating engines to shipyards, municipal utilities, institutional and industrial organizations, sewage treatment plants, nuclear power plants, and offshore oil and gas platforms. The company was founded in 2002 and is headquartered in Charlotte, North Carolina..

First Busey Corp (NASDAQ:BUSE) - First Busey Corporation operates as the bank holding company for Busey Bank that provides retail and commercial banking products and services to individual, corporate, institutional, and governmental customers in the United States. Its deposit products include noninterest-bearing demand, interest-bearing demand, savings, money market, and time deposits. The company s loan products portfolio comprises commercial, agricultural, and real estate loans; individual, installment, first mortgage, and second mortgage loans; and commercial real estate, residential real estate, and consumer loans. It also offers money transfer, safe deposit, IRA, Keogh and other fiduciary, automated banking, and automated fund transfer services. In addition, the company provides investment management, trust, and estate advisory services, as well as financial planning services for individuals; investment management, business succession planning, and employee retirement planning services for businesses; investment management, investment strategy consulting, and fiduciary services for foundations; and brokerage related services. Further, it offers pay processing solutions, including walk-in payment processing for payments delivered by customers to retail pay agents; online bill payment solutions for payments made by customers on a billing company s Website; customer service payments for payments accepted over the telephone; direct debit services; electronic concentration of payments delivered by the automated clearing house network; money management software and credit card networks; and lockbox remittance processing of payments delivered by mail. As of July 24, 2012, the company had 31 full service and 4 limited service banking centers serving downstate Illinois; a full service banking center in Indianapolis, Indiana; and 7 full service banking centers serving southwest Florida. First Busey Corporation was founded in 1868 and is headquartered in Champaign, Illinois..

Renasant Corp (NASDAQ:RNST) - Renasant Corporation operates as a holding company for the Renasant Bank that provides financial and insurance services to retail and commercial customers. The company offers checking accounts, money market accounts, savings accounts, certificates of deposit, interest-bearing demand deposits, time deposits, individual retirement accounts, and health savings accounts. It also provides real estate construction loans, including loans for the construction of single family residential properties, multi-family properties, and commercial projects; real estate 1-4 family mortgages; real estate commercial mortgage loans; installment loans to individuals; business and personal loans; and equipment leasing, as well as safe deposit and night depository facilities. In addition, the company offers fiduciary services; administers qualified retirement plans, profit sharing and other employee benefit plans, personal trusts, and estates; and provides annuities, mutual funds and other investment services through a third party broker-dealer. Further it offers commercial and personal insurance through carriers. As of February 29, 2012, the company operated 78 banking and financial services offices in north and north central Mississippi, west and middle Tennessee, north and central Alabama, and north Georgia. Renasant Corporation was founded in 1904 and is headquartered in Tupelo, Mississippi..

Xenoport Inc (NASDAQ:XNPT) - XenoPort, Inc., a biopharmaceutical company, focuses on developing and commercializing a portfolio of internally discovered product candidates for the potential treatment of neurological disorders. The company s lead product includes Gabapentin Enacarbil, a transported prodrug of Gabapentin for the treatment of moderate-to-severe primary restless legs syndrome (RLS) in adults. It markets Gabapentin Enacarbil under the Horizant name in the United States, as well as under the Regnite name in Japan and five other Asian countries. The company is also developing Arbaclofen Placarbil, which is in Phase III clinical trial for the treatment of spasticity in patients with MS, stroke and cerebral palsy, and spinal cord injury; XP21279, a transported prodrug of Levodopa, which is in Phase II clinical trial for the treatment of Parkinson s disease; and XP23829, a novel prodrug of Monomethyl Fumarate that is in preclinical stage for the potential treatment for relapsing-remitting MS. It has strategic alliances with Astellas Pharma Inc. and Glaxo Group Limited to develop and commercialize Gabapentin Enacarbil. XenoPort, Inc. was founded in 1999 and is based in Santa Clara, California..

Dresser-Rand Group Inc (NYSE:DRC) - Dresser-Rand Group Inc., together with its subsidiaries, engages in the design, manufacture, sale, and servicing of custom-engineered rotating equipment solutions to the oil, gas, chemical, petrochemical, process, power, military, and other industries worldwide. It offers various turbo products, such as axial flow compressors, legacy centrifugal compressors, warm-gas expanders, and hot-gas expanders, as well as steam, gas, and power turbines and control systems, which are used in gas lift and injection, gas gathering, CO2 compression for enhanced oil recovery, storage and transmission, synthetic fuels, ethylene, fertilizer, refineries and chemical production, carbon capture and sequestration, and compressed air energy storage applications. The company also provides reciprocating compressors for lower volume/higher compression ratio applications; and steam turbines, including mechanical drive steam turbines and turbine generator sets, which are used primarily to drive pumps, fans, blowers, generators, and compressors. In addition, it offers a range of aftermarket parts and services. Dresser-Rand Group Inc. markets its products and services through its direct sales/service personnel and independent representatives. The company was founded in 2004 and is headquartered in Houston, Texas..

ZIOPHARM Oncology Inc (NASDAQ:ZIOP) - ZIOPHARM Oncology, Inc., a biopharmaceutical company, focuses on the development and commercialization of new cancer therapies. Its lead candidate, Palifosfamide (ZIO-201), a potent bi-functional DNA alkylating agent, is under Phase III trial for the treatment of first-line metastatic soft tissue sarcoma, as well as in a pivotal Phase III trial for first-line metastatic small cell lung cancer. The company s portfolio of clinical-stage product candidates also include IL-12 DNA, which is being tested in a Phase 2 study using synthetic biology to enable controlled, local delivery of therapeutic interleukin-12; Indibulin (ZIO-301), a novel, tubulin binding agent under Phase I/II trial in metastatic breast cancer; and Darinaparsin (ZIO-101), a novel mitochondrial- and hedgehog-targeted agent. In addition, its portfolio comprises various research-stage candidates. The company s DNA therapeutics are being developed in partnership with Intrexon Corporation through a synthetic biology platform that allows for targeted, controlled production of therapies in humans with a biologic on/off switch. ZIOPHARM Oncology, Inc. was founded in 2003 and is headquartered in New York, New York with operations center located in Boston, Massachusetts..

SqueezeTrigger.com has built a massive database that collects, analyzes and publishes multiple proprietary trading strategies that predict price moves in stocks, commodities and currencies. The data has then been integrated into an automated trading platform which can be used to connect to a live online broker and automate your trading of each of the strategies highlighted. It is extremely powerful with lightening fast execution at a very low price. Both the trading software and SqueezeTrigger data feed are available at http://www.squeezetrigger.com

www.squeezetrigger.com monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements".

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO.

INVESTMENTS & TRADING

SqueezeTrigger -- 25 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

About SQUEEZETRIGGER.COM

WWW.SQUEEZETRIGGER.COM is a service designed to help bonafide shareholders of publicly traded US companies fight short selling. SqueezeTrigger.com has built a proprietary database that uses Threshold list feeds and short sale time and sale data from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short trades.

SQUEEZETRIGGER.COM has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2.5 billion short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like SqueezeTrigger.com to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each montha'a"s short transactions, SQUEEZETRIGGER.COM provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by SQUEEZETRIGGER.COM, based upon information believed to be reliable. The information contained herein is not guaranteed by SQUEEZETRIGGER.COM to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion.

Occassionally companies pay $995.00 to purchase data for information provided in reports issued by BUYINS.NET, a company affiliated with SQUEEZETRIGGER.COM. The data service can be cancelled at any time. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SQUEEZETRIGGER.COM is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. SQUEEZETRIGGER.COM will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

SQUEEZETRIGGER.COM and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of SQUEEZETRIGGER.COM, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting SQUEEZETRIGGER.COM or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. Global Automated Trading Systems, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to SQUEEZETRIGGER.COM and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. SQUEEZETRIGGER.COM does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. SQUEEZETRIGGER.COM places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SQUEEZETRIGGER.COM undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected", "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.squeezetrigger.com +1-800-715-9999 Tom@squeezetrigger.com

SqueezeTrigger is a registered trademark, Reg. No. 3,120,641